|
Market Closed -
Nasdaq
00:00:00 17/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 37.19 USD | -2.64% |
|
-4.79% | +49.87% |
| 10-16 | William Blar Initiates Coverage on Edgewise Therapeutics With Outperform Rating | MT |
| 10-08 | Edgewise Therapeutics Doses First Patient in Trial of Investigational Heart Failure Drug | MT |
| Market Cap | 4.04B 3.59B 3.33B 3.03B 5.71B 383B 5.8B 40B 15.68B 200B 15.16B 14.84B 638B | P/E 2026 * |
21.2x | P/E 2027 * | -18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.78B 2.47B 2.29B 2.08B 3.93B 264B 4B 27.53B 10.79B 138B 10.43B 10.21B 439B | EV / Sales 2026 * |
21.6x | EV / Sales 2027 * | 74.6x |
| Free-Float |
99.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EWTX | Delayed | |
CBOE
| EWTX | Real-time |
Last Transcript: Edgewise Therapeutics, Inc.
| 1 day | -2.64% | ||
| 1 week | -4.79% | ||
| Current month | -8.40% | ||
| 1 month | -17.94% | ||
| 3 months | -6.46% | ||
| 6 months | +8.02% | ||
| Current year | +49.87% |
| 1 week | 35.63 |  | 38.53 |
| 1 month | 35.63 | | 45.99 |
| Current year | 22.78 | | 48.51 |
| 1 year | 14.68 | | 48.51 |
| 3 years | 5.12 | | 48.51 |
| 5 years | 5.12 | | 48.51 |
| 10 years | 5.12 | | 48.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alan Russell
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/2017 |
Kevin Koch
CEO | Chief Executive Officer | 65 | 01/08/2017 |
Michael Nofi
DFI | Director of Finance/CFO | 55 | 10/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Koch
BRD | Director/Board Member | 65 | 01/06/2017 |
Peter Thompson
CHM | Chairman | 67 | 01/08/2017 |
Alan Russell
BRD | Director/Board Member | 56 | 01/08/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Free | Director | 308 | 0.0003% | ||
| 13/08/26 | Sell | Chief Technology Officer | -2,919 | 0.0027% | ||
| 12/08/26 | Free | Chief Financial Officer | 48,750 | 0.0453% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.64% | -4.79% | +146.95% | +415.10% | 4.04B | |
| -6.60% | -8.56% | +49.38% | +64.90% | 65B | |
| +0.03% | +5.56% | +9.10% | +75.22% | 51.2B | |
| -4.09% | -0.11% | +2.22% | +55.67% | 51.19B | |
| -1.53% | +2.70% | +30.48% | +41.25% | 43.93B | |
| -1.34% | +4.12% | +16.64% | +120.28% | 41.96B | |
| -5.97% | -6.22% | +228.95% | +483.48% | 38.14B | |
| +6.53% | +8.02% | +16.40% | +56.32% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| -1.07% | +2.33% | +19.43% | +20.40% | 22.5B | |
| Average | -1.76% | -0.79% | +55.66% | +133.44% | 37.64B | |
| Weighted average by Cap. | -2.20% | -0.54% | +45.35% | +106.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 115M 106M 96.58M 182M 12.23B 185M 1.28B 500M 6.38B 484M 473M 20.34B | 39.17M 34.82M 32.27M 29.36M 55.4M 3.72B 56.29M 388M 152M 1.94B 147M 144M 6.18B |
| Net income | 210M 187M 173M 158M 298M 19.97B 302M 2.08B 817M 10.42B 790M 773M 33.22B | -220M -195M -181M -165M -311M -20.84B -316M -2.17B -853M -10.87B -824M -806M -34.67B |
| Net Debt | -1.26B -1.12B -1.04B -944M -1.78B -119B -1.81B -12.47B -4.89B -62.35B -4.73B -4.62B -199B | -1.12B -993M -920M -837M -1.58B -106B -1.61B -11.06B -4.34B -55.33B -4.19B -4.1B -176B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | $37.19 | -2.64% | 1,305,481 |
| 15/10/26 | $38.20 | +3.19% | 1,837,467 |
| 14/10/26 | $37.02 | +2.04% | 1,446,128 |
| 13/10/26 | $36.28 | -5.64% | 810,154 |
| 12/10/26 | $38.45 | -1.56% | 1,536,717 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EWTX Stock
Select your edition
All financial news and data tailored to specific country editions
